biguanides has been researched along with 2,4-thiazolidinedione in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Haeften, TW; Wolffenbuttel, BH | 1 |
| Hunabiki, A; Kasuga, M; Morita, S | 1 |
| Feinglos, MN; Luna, B | 1 |
| Rybka, J | 1 |
| Drexler, AJ; Robertson, C | 1 |
| Hotta, N | 1 |
| McCormick, M; Quinn, L | 1 |
| Inzucchi, SE; Mayerson, AB | 1 |
| Sakura, H | 1 |
| Basu, A; Kudva, YC; Zangeneh, F | 1 |
| Iwamoto, Y | 1 |
| Abu-Baker, A; Busch, RS; Kane, MP | 1 |
| Hara, K; Moriyama, H; Nagata, M; Yasuda, H; Yokono, K | 1 |
| Cao, Y; Chai, Y; Lu, F; Zhu, Q | 1 |
| Abe, J; Hara, H; Kinosada, Y; Nagasawa, H; Nakamura, M; Nishibata, Y; Suzuki, Y; Umetsu, R | 1 |
| Araki, E; Broedl, UC; Kim, G; Koiwai, K; Salsali, A; Tanaka, Y; Taniguchi, A; Tanizawa, Y; Woerle, HJ | 1 |
| Chu, WM; Ho, HE; Huang, KH; Lee, MC; Li, YC; Liou, YS; Tsan, YT; Wang, YH | 1 |
12 review(s) available for biguanides and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Insulin; Lipids; Prospective Studies; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; United Kingdom | 1995 |
[Etiology and therapy of insulin resistance].
Topics: Animals; Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Life Style; Obesity; Risk Factors; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 1999 |
Oral agents in the management of type 2 diabetes mellitus.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2001 |
[Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2001 |
Type 2 diabetes. How new insights, new drugs are changing clinical practice.
Topics: Acarbose; Aged; Biguanides; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Thiazoles; Thiazolidinediones; Treatment Outcome | 2001 |
[Clinical difference between thiazolidinediones and biguanides].
Topics: Biguanides; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin Resistance; Thiazoles; Thiazolidinediones | 2001 |
Treatment of type 2 diabetes mellitus: pharmacologic intervention.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Type 2 diabetes therapy. A pathophysiologically based approach.
Topics: alpha-Glucosidases; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
[Combination therapy with biguanides].
Topics: Acarbose; Biguanides; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone | 2002 |
Insulin sensitizers.
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Thiazoles; Thiazolidinediones | 2003 |
[Selection of oral antidiabetic drugs].
Topics: Acarbose; Administration, Oral; Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Indoles; Isoindoles; Risk; Sulfonylurea Compounds; Thiazolidinediones | 2005 |
The utility of oral diabetes medications in type 2 diabetes of the young.
Topics: Administration, Oral; Biguanides; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosidases; Humans; Hypoglycemic Agents; Injections; Insulin; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2005 |
1 trial(s) available for biguanides and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Benzhydryl Compounds; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2015 |
4 other study(ies) available for biguanides and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Biguanide, but not thiazolidinedione, improved insulin resistance in Werner syndrome.
Topics: Biguanides; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Middle Aged; Thiazolidinediones; Werner Syndrome | 2010 |
Rapid on-site TLC-SERS detection of four antidiabetes drugs used as adulterants in botanical dietary supplements.
Topics: Biguanides; Chromatography, Thin Layer; Dietary Supplements; Drug Contamination; Hypoglycemic Agents; Limit of Detection; Plant Preparations; Spectrum Analysis, Raman; Thiazolidinediones | 2014 |
[Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
Topics: Acarbose; Administration, Oral; Adverse Drug Reaction Reporting Systems; Benzamides; Biguanides; Data Mining; Databases, Pharmaceutical; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Pyrazines; Risk; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles | 2014 |
The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: An 8-year population-based study.
Topics: Administration, Oral; Age Factors; Aged; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Middle Aged; Practice Patterns, Physicians'; Sulfonylurea Compounds; Taiwan; Thiazolidinediones | 2017 |